RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,897 | -67.0% | 62,273 | -18.4% | 0.00% | – |
Q3 2022 | $33,000 | -64.9% | 76,330 | -31.3% | 0.00% | – |
Q2 2022 | $94,000 | -93.7% | 111,100 | -59.3% | 0.00% | – |
Q1 2022 | $1,502,000 | -42.1% | 272,737 | +1.7% | 0.00% | – |
Q4 2021 | $2,595,000 | +16.3% | 268,082 | +114.9% | 0.00% | – |
Q3 2021 | $2,231,000 | -25.6% | 124,723 | +1.5% | 0.00% | – |
Q2 2021 | $2,999,000 | +194.9% | 122,862 | +220.3% | 0.00% | – |
Q1 2021 | $1,017,000 | +142.7% | 38,356 | -30.6% | 0.00% | – |
Q4 2020 | $419,000 | +235.2% | 55,299 | +121.8% | 0.00% | – |
Q3 2020 | $125,000 | -90.5% | 24,928 | -88.7% | 0.00% | – |
Q2 2020 | $1,317,000 | +382.4% | 220,195 | +257.6% | 0.00% | – |
Q1 2020 | $273,000 | -72.5% | 61,574 | -40.9% | 0.00% | – |
Q4 2019 | $991,000 | -8.4% | 104,261 | -24.3% | 0.00% | – |
Q3 2019 | $1,082,000 | -9.7% | 137,782 | +80.9% | 0.00% | – |
Q2 2019 | $1,198,000 | -21.4% | 76,145 | -9.6% | 0.00% | – |
Q1 2019 | $1,525,000 | +62.4% | 84,247 | +44.4% | 0.00% | – |
Q4 2018 | $939,000 | -30.9% | 58,359 | +3.1% | 0.00% | – |
Q3 2018 | $1,359,000 | – | 56,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |